Related Experiment Videos
Hyperglycemia in patients administered dexamethasone for craniotomy
Michael B Lukins1, Pirjo H Manninen
1Department of Anesthesia, Toronto Western Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Anesthesia and Analgesia
|March 23, 2005
Summary
Administering dexamethasone during neurosurgery can significantly increase blood glucose levels in patients. Monitoring blood glucose for 12 hours is recommended for non-diabetic patients receiving dexamethasone during surgery.
Area of Science:
- Neurosurgery
- Endocrinology
- Pharmacology
Background:
- Hyperglycemia during neurosurgery is linked to increased neurological injury risk.
- Dexamethasone is known to elevate blood glucose levels during surgical procedures.
Purpose of the Study:
- To investigate the impact of intraoperative and preoperative dexamethasone on blood glucose concentrations in non-diabetic patients undergoing craniotomy.
- To compare blood glucose changes in patients receiving dexamethasone versus those who did not.
Main Methods:
- Prospective, nonrandomized study involving 34 non-diabetic patients undergoing craniotomy.
- Documented blood glucose changes for 12 hours post-induction.
- Compared three groups: no dexamethasone, intraoperative dexamethasone only, and preoperative/intraoperative dexamethasone.
Main Results:
- All groups showed increased blood glucose levels post-induction.
- Patients receiving intraoperative dexamethasone (with or without preoperative use) exhibited significantly higher peak blood glucose concentrations compared to the no-dexamethasone group.
- The highest peak glucose levels (11.0 +/- 2.0 mmol/L) were observed in patients newly administered dexamethasone intraoperatively, occurring approximately 9 hours after anesthesia induction.
Conclusions:
- Newly administered dexamethasone, particularly intraoperatively, leads to substantial hyperglycemia in non-diabetic patients undergoing neurosurgery.
- Blood glucose monitoring for at least 12 hours is crucial for non-diabetic patients receiving dexamethasone during craniotomy to mitigate potential neurological complications.